[Results of cytostatic and radiologic treatment of chronic myelocytic leukemia (analysis of 11 cases)].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001856:Bone Marrow Examination; D002066:Busulfan / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D007964:Leukocytosis / Q000209:etiology; D008297:Male; D008353:Mannitol / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013160:Splenic Neoplasms / Q000532:radiotherapy; D013163:Splenomegaly / Q000209:etiology; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D003561:Cytarabine; D008353:Mannitol; D014750:Vincristine; D015122:Mercaptopurine; D002066:Busulfan; D011241:Prednisone
Résultat des traitements cytostatiques et radiologiques des leucémies myélocytaires chroniques: (analyse de 11 cas)